Innovator versus Generic

European Pharmaceutical Contractor
June 2011

The financial investment made to develop and bring to market a new pharmaceutical compound is enormous. In the June 2011 issue of European Pharmaceutical Contractor, partner Raymond Mandra and associate Kimberley Gavin discuss ways to protect that investment via patents that claim alternative forms of the new chemical entity.

View Attachment (PDF)